2025年的暫定議程

CHI第三屆年度會議

Clinical Trial Venture, Innovation & Partnering
臨床試驗風險投資、創新和合作夥伴關係

Accelerating Innovation, Accessibility and Scale
加速創新可及性規模

2025年2月4日～5日（所有時間均為美國東部標準時間）

SCOPE Summit 的「臨床試驗風險投資、創新和合作」會議將於 2025 年 2 月 4~5 日在佛羅里達州奧蘭多舉行。 該頂級會議將與第 16 屆 SCOPE 峰會（臨床運營高管峰會）一起舉行。 第三屆年度臨床試驗風險投資、創新和合作夥伴關係會議將彙集臨床試驗領域的高級投資者、高管、企業家和初創公司領導者。這項高級別活動內容包括發人深省的行業主導小組討論、爐邊談話以及為首席執行官、投資者和潛在收購者提供的眾多交流機會，以助您建立有意義的人脈。誠摯邀請您參加本次以風險和創新為焦點的會議，以獲得寶貴的策略見解、坦誠的觀點以及合作和投資的實用商業建議。此外，您還將有機會探索展廳，與該領域的新興企業和老牌企業建立聯繫，使您能夠掌握行業的發展方向。
Preliminary Agenda

Co-Chair Welcome Remarks

Jessica J. Federer, Board Member, Angelini Ventures

NAVIGATING THE CLINICAL TRIAL INVESTMENT LANDSCAPE: INNOVATION, OPPORTUNITIES, AND MARKET INSIGHTS

KEYNOTE:

Unlocking Opportunities: Market Overview and Investment Landscape in Clinical Trial Venture and Innovation

Shane C. Senior, Managing Director & Owner, Crosstree Capital Partners, Inc.

PANEL DISCUSSION:

Where Are Investors Placing Their Bets? An Oxford Style Debate

PANEL MODERATOR:

Jessica J. Federer, Board Member, Angelini Ventures

PANELISTS:

Dana Callow, Founder & Managing Partner, Boston Millennia Partners

Sunny Kumar, Partner, GSR Ventures

Carrie Williams, Vice President & Partner, McKesson Ventures

PANEL DISCUSSION:

Identifying and Addressing Pharma's Unmet Needs: Strategic Insights for Investment

PANEL MODERATOR:

Jodi Akin, Founding CEO, Hawthorne Effect, Inc.

PANELISTS:

Brian Matesic, Principal, Norwest Venture Partners

PANEL DISCUSSION:

How Is Pharma Rethinking Clinical Trials and Investments?

PANEL MODERATOR:

Jeremy P. Goldberg, Operating Partner, Healthcare, Arsenal Capital Partners

PANELISTS:

John R. Pavletic, Executive Director, Lilly Ventures

Dave Stevenson, Managing Director, Merck Global Health Innovation Fund

INVESTING IN THE FUTURE OF CLINICAL TRIALS: TRENDS, RISKS, AND POTENTIAL

Co-Chair Remarks

Rana Lonnen, Managing Director, Novartis

PANEL DISCUSSION:

Leading the Future of Clinical Trials: CEO and Founders Perspectives on Innovation and Transformation

PANEL MODERATOR:

Rana Lonnen, Managing Director, Novartis

PANELISTS:

Scott Chetham, PhD, CEO & Co-Founder, Faro Health

Emmanual Walckenaer, CEO, Yseop

Chairperson's Remarks

Zach Taft, CEO, IgniteData

PANEL DISCUSSION:

Investing in AI for Clinical Trials: Navigating Risk and Maximizing ROI

PANEL MODERATOR:

Mitesh Rao, MD, Founder & CEO, OMNY

PANELISTS:

Sameer Badlani, MD, FACP, Chief Strategy Officer & Chief Digital Officer, Fairview Health Services

Jill Johnston, Chief Innovation Officer, WCG Clinical

Interviewed By:

Brigham Hyde, CEO, Atropos Health & Venture Partner, Audere Capital LLC, Atropos Health

PANEL DISCUSSION:

Unlocking the Patient Recruitment Puzzle: A Smart Investment in Enhancing the Patient Experience and the Future of Trials

PANEL MODERATOR:

Laura Y. Hilty, Principal, Investments & Growth, HealthX Ventures

PANELISTS:

Denise Bronner, PhD, Founder & CEO, Empactful Ventures

Eirini Scholosser, Founder & CEO, Dyania Health

Delmonize Smith, PhD, Co-Founder & CEO, Acclinate

Co-Chair Closing Remarks

Sunny Kumar, Partner, GSR Ventures


* 活動內容有可能不事先告知作更動及調整。